Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors
May 15, 2024 08:00 ET
|
Osmol Therapeutics
NEW HAVEN, Conn., May 15, 2024 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for...
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
March 04, 2024 08:00 ET
|
Osmol Therapeutics
Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer